Literature DB >> 20173350

Calcium-corrected intact PTH: a clinically useful parameter for quantifying parathyroid function in patients undergoing hemodialysis.

Shozo Yano1, Edward M Brown, Hirofumi Takase, Akihiko Wada, Keiko Suzuki, Akira Kobayashi, Toshitsugu Sugimoto.   

Abstract

BACKGROUND/AIMS: Serum parathyroid hormone (PTH) concentration provides a rough index of the severity of secondary hyperparathyroidism (SHPT) due to chronic renal failure. Since serum PTH inversely related to calcium (Ca) level, we attempted to create a new index based on the relationship.
METHODS: Our subjects were 70 patients undergoing maintenance hemodialysis (HD) in a single facility. Using multiple pairs of serum Ca corrected for albumin (cCa) and intact PTH (iPTH) values drawn simultaneously, we determined the steepest slope of cCa-iPTH relationship for each individual patient to get a line closely resembling the cCa-PTH sigmoidal curve.
RESULTS: Based on the slopes, the following equation was obtained: iPTH2 = iPTH1 + (cCa1 - cCa2) x (43 + 0.47 x iPTH1), where the PTH values at any 2 arbitrary values of cCa1 and cCa2 were assumed to be iPTH1 and iPTH2, respectively. When 'corrected PTH' is defined as the predicted value of iPTH at cCa = 9.0 mg/dl, its correlation was better than iPTH with the total volume of the parathyroid glands estimated by ultrasonography. Similar results were found in 30 parathyroidectomized patients at other facilities.
CONCLUSION: 'Corrected PTH' may represent a useful parameter for assessing the severity of SHPT from single determinations of cCa and iPTH drawn at the same time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173350     DOI: 10.1159/000286350

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  1 in total

1.  Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report.

Authors:  Giovanni Conzo; Alessandra F Perna; Salvatore Napolitano; Claudio Mauriello; Claudio Gambardella; Ersilia Satta; Giuseppe Ciancia; Giovanbattista Capasso; Luigi Santini
Journal:  J Med Case Rep       Date:  2012-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.